Skip to search formSkip to main contentSkip to account menu

BIIE 0246

Known as: BIIE-0246, BIIE0246, N(2)-((1-(2-(4-(5,11-dihydro-6(6H)-oxodibenz(b,e)azepin-11-yl)-1-piperazinyl)-2-oxoethyl)cyclopentyl)acetyl)-N-(2-(1,2-dihydro-3,5(4H)-dioxo-1,2-diphenyl-3H-1,2,4-triazol-4-yl)ethyl)argininamide 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2012
Highly Cited
2012
Stress has long been thought of to be associated with increased risk of cancer. Chronic stress is associated with elevated levels… 
2007
2007
Peptide YY (PYY)(3-36), released by intestinal lipid elicits functional effects that comprise the intestinal feedback response to… 
2003
2003
This study investigated the effects of galanin (GAL) on inhibition of cholinergic (vagal) activity in the mouse heart using… 
Highly Cited
2001
Highly Cited
2001
This study investigated the effects of BIIE0246, a novel neuropeptide Y (NPY) Y2 receptor antagonist, on the inhibition of… 
Highly Cited
2000
Highly Cited
2000
BIIE0246, a newly synthesized non‐peptide neuropeptide Y (NPY) Y2 receptor antagonist, was able to compete with high affinity (8…